| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $643K | -37.0% |
| Cost of Revenue | $924K | -19.6% |
| Gross Profit | -$281K | -119.7% |
| R&D Expense | $1.5M | -10.1% |
| SG&A Expense | $7.0M | +33.3% |
| Operating Income | -$9.6M | -14.7% |
| Pre-tax Income | -$10.1M | +70.0% |
| Income Tax | $2K | -88.9% |
| Net Income | -$10.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172K | +265.9% |
| Accounts Receivable | $213K | +40.5% |
| Current Assets | $3.6M | +893.7% |
| Total Assets | $3.7M | +704.9% |
| Current Liabilities | $19.2M | +49.8% |
| Long-term Debt | $2.3M | +398.7% |
| Total Liabilities | $19.7M | +47.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -184.9% |
| Capital Expenditures | $51K | +16.6% |
| Investing Cash Flow | -$2.0M | -4404.5% |
| Financing Cash Flow | $9.1M | +207.8% |
| Free Cash Flow | -$7.0M | -186.0% |
| +56.4% |
| EPS (Basic) | -$0.36 | +63.3% |
| EPS (Diluted) | -$0.36 | +63.3% |
| Stockholders' Equity |
| -$15.9M |
| -24.0% |